251 related articles for article (PubMed ID: 17124079)
21. [Cutaneous lymphomas: new entities and rare variants].
Kempf W; Mitteldorf C
Pathologe; 2015 Feb; 36(1):62-9. PubMed ID: 25589355
[TBL] [Abstract][Full Text] [Related]
22. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis and Management of Cutaneous Lymphomas Including Cutaneous T-cell Lymphoma.
Zic JA
Med Clin North Am; 2021 Jul; 105(4):737-755. PubMed ID: 34059248
[TBL] [Abstract][Full Text] [Related]
24. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
25. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.
Santucci M; Pimpinelli N; Massi D; Kadin ME; Meijer CJ; Müller-Hermelink HK; Paulli M; Wechsler J; Willemze R; Audring H; Bernengo MG; Cerroni L; Chimenti S; Chott A; Díaz-Pérez JL; Dippel E; Duncan LM; Feller AC; Geerts ML; Hallermann C; Kempf W; Russell-Jones R; Sander C; Berti E;
Cancer; 2003 Feb; 97(3):610-27. PubMed ID: 12548603
[TBL] [Abstract][Full Text] [Related]
26. Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone.
Davis TH; Morton CC; Miller-Cassman R; Balk SP; Kadin ME
N Engl J Med; 1992 Apr; 326(17):1115-22. PubMed ID: 1532439
[TBL] [Abstract][Full Text] [Related]
27. WHO-EORTC classification for cutaneous lymphomas.
Willemze R; Jaffe ES; Burg G; Cerroni L; Berti E; Swerdlow SH; Ralfkiaer E; Chimenti S; Diaz-Perez JL; Duncan LM; Grange F; Harris NL; Kempf W; Kerl H; Kurrer M; Knobler R; Pimpinelli N; Sander C; Santucci M; Sterry W; Vermeer MH; Wechsler J; Whittaker S; Meijer CJ
Blood; 2005 May; 105(10):3768-85. PubMed ID: 15692063
[TBL] [Abstract][Full Text] [Related]
28. WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects.
Burg G; Kempf W; Cozzio A; Feit J; Willemze R; S Jaffe E; Dummer R; Berti E; Cerroni L; Chimenti S; Diaz-Perez JL; Grange F; Harris NL; Kazakov DV; Kerl H; Kurrer M; Knobler R; Meijer CJ; Pimpinelli N; Ralfkiaer E; Russell-Jones R; Sander C; Santucci M; Sterry W; Swerdlow SH; Vermeer MH; Wechsler J; Whittaker S
J Cutan Pathol; 2005 Nov; 32(10):647-74. PubMed ID: 16293178
[TBL] [Abstract][Full Text] [Related]
29. Primary cutaneous T-cell lymphoma: a review of the most common entities with focus on recent updates.
Saleh JS; Subtil A; Hristov AC
Hum Pathol; 2023 Oct; 140():75-100. PubMed ID: 37802757
[TBL] [Abstract][Full Text] [Related]
30. Survival data for 299 patients with primary cutaneous lymphomas: a monocentre study.
Hallermann C; Niermann C; Fischer RJ; Schulze HJ
Acta Derm Venereol; 2011 Sep; 91(5):521-5. PubMed ID: 21547335
[TBL] [Abstract][Full Text] [Related]
31. The applicability of the new WHO-EORTC classification of primary cutaneous lymphomas to a single referral center.
Khamaysi Z; Ben-Arieh Y; Izhak OB; Epelbaum R; Dann EJ; Bergman R
Am J Dermatopathol; 2008 Feb; 30(1):37-44. PubMed ID: 18212543
[TBL] [Abstract][Full Text] [Related]
32. Clinical manifestations and pathogenesis of cutaneous lymphomas: current status and future directions.
Rubio-Gonzalez B; Zain J; Rosen ST; Querfeld C
Br J Haematol; 2017 Jan; 176(1):16-36. PubMed ID: 27782301
[TBL] [Abstract][Full Text] [Related]
33. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
34. Non-mycosis fungoides cutaneous T-cell lymphoma: reclassification according to the WHO-EORTC classification.
Weaver J; Mahindra AK; Pohlman B; Jin T; Hsi ED
J Cutan Pathol; 2010 May; 37(5):516-24. PubMed ID: 20132421
[TBL] [Abstract][Full Text] [Related]
35. HTLV-1-negative pleomorphic T-cell lymphoma of the skin: the clinicopathological correlations and natural history of 15 patients.
Sterry W; Siebel A; Mielke V
Br J Dermatol; 1992 May; 126(5):456-62. PubMed ID: 1610685
[TBL] [Abstract][Full Text] [Related]
36. EORTC classification for primary cutaneous lymphomas: a comparison with the R.E.A.L. Classification and the proposed WHO Classification.
Willemze R; Meijer CJ
Ann Oncol; 2000; 11 Suppl 1():11-5. PubMed ID: 10707772
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous T-cell lymphomas: a review with emphasis on new treatment approaches.
Querfeld C; Rosen ST; Kuzel TM; Guitart J
Semin Cutan Med Surg; 2003 Sep; 22(3):150-61. PubMed ID: 14649582
[TBL] [Abstract][Full Text] [Related]
38. Management of the cutaneous peripheral T-cell lymphomas: when subtypes matter.
Choi MY; Lechowicz MJ
Cancer J; 2012; 18(5):439-44. PubMed ID: 23006949
[TBL] [Abstract][Full Text] [Related]
39. [Current therapy concepts in cutaneous T-cell lymphomas].
Nestle FO; Häffner AC; Schmid MH; Dummer R; Burg G
Schweiz Med Wochenschr; 1997 Feb; 127(8):311-20. PubMed ID: 9157537
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
